Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Seagen Inc. SGEN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$171.82
-24.9%
Metric TTM (2022-12 – 2023-09)
Operating Cash Flow $-540.15M
Capital Expenditure $-161.06M
Free Cash Flow $-701.21M

People Also View

ALNY
ALNY
Alnylam Pharmaceuticals, Inc.
$339.41
+1.92%
 UTHR
UTHR
United Therapeutics Corporation
$578.54
+0.16%
 INCY
INCY
Incyte Corporation
$97.69
+2.24%
 ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
 EXEL
EXEL
Exelixis, Inc.
$45.86
+2.00%
 MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 BMRN
BMRN
BioMarin Pharmaceutical Inc.
$55.47
+1.08%
 HALO
HALO
Halozyme Therapeutics, Inc.
$67.31
+0.49%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message